The path forward with the FDA’s Dr. Janet Woodcock


FDA Senior Advisor Dr. Janet Woodcock joins Meg Tirrell to talk monoclonal antibody treatments, Operation Warp Speed, and how to run better clinical trials.

For more exclusive insights from our reporters and speakers, sign up for our Healthy Returns newsletter to get the latest delivered straight to your inbox weekly. And for a front row seat at CNBC Events, you can hear directly from the visionary executives, innovators, leaders and influencers taking the stage in “The Keynote Podcast.” Listen now, however you get your podcasts.



Source link

Discover

Sponsor

Latest

Airbnb hit with proposed class-action lawsuit from host missing payments

Airbnb CEO Brian Chesky.John van Hasselt | Corbis | Getty ImagesA short-term rental vacation host has filed a proposed class action lawsuit against...

The source of Biden campaign’s ‘Sun Belt’ confidence

RealClearPolitics associate editor and columnist A.B. Stoddard broke down why Democratic presidential candidate Joe Biden's campaign "has Sun Belt confidence," in an election...

SoftBank may buy $25% of Adam Neumann’s WeWork stake for $480 million

Adam Neumann, CEO of WeWork.Eduardo Munoz | ReutersWeWork co-founder Adam Neumann and SoftBank are nearing a settlement agreement that would entitle the former...

Ford announces $2 billion convertible notes offering

DETROIT – Ford Motor plans to raise about $2 billion through an offering of five-year convertible notes, the company announced Tuesday.The automaker intends...

Cannabis, clean energy and commodities: ETF themes to watch as 2021’s first quarter comes to a close

With U.S. exchange-traded funds approaching $6 trillion in assets under management, several key areas are worth watching, says Old Mission's Harry Whitton. Source link...